Access cutting-edge neuroblastoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access neuroblastoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroblastoma treatment provided free
The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this neuroblastoma clinical trial in New York, NY
If you're searching for neuroblastoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.